This case study describes the inception, development and implementation of the Health and Sustainability Guidelines for Federal Concessions and Vending Operations.
Office of Science and Data Policy (SDP)
The Office of Science and Data Policy is the departmental focal point for policy research, analysis, evaluation, and coordination of department-wide public health science policy and data policy activities and issues. The Office provides authoritative advice and analytical support to the ASPE and departmental leadership on public health science policy and data policy issues and initiatives, coordinates science and data policy issues of interagency scope within HHS, and manages interagency initiatives in science policy and data policy. The Office works closely with staff from across the Department on strategic plan development and implementation efforts. The Offices also carries out a program of policy research, analysis, evaluation, and data development in these issues.
The Office of Science and Data Policy includes several components:
- Division of Science and Public Health Policy
- Division of Evidence, Evaluation and Data Policy
- Division of Strategic Planning
Topic Areas:
- HHS Data Council
- Regulatory Impact Analysis
- Strategic Planning
- Information Quality Guidelines
- Prevention and wellness
- Public health systems and functions
- Food safety and nutrition
- Drugs and devices
- Tobacco control and prevention
- Biomedical research and development
- Economic analysis
- Emergency preparedness, response, and recovery
- Data and statistical policy
- Health disparities and vulnerable populations
- Health information technology
- Microsimulation
- Privacy policy
Reports
Displaying 121 - 130 of 179. 10 per page. Page 13.
Advanced SearchDemystifying Microsimulation Meeting Report
On Friday, November 16, 2012, the Office of the Assistant Secretary for Planning and Evaluation (ASPE) ofthe U.S.
Policies and Principles for Assuring Scientific Integrity - Archive
The information provided here is archival and is no longer being updated. For current information, please visit Scientific Integrity at HHS.
Improving Data for Decision Making: HHS Data Collection Strategies for a Transformed Health System
EXECUTIVE SUMMARY Contents Introduction and Background Data Needs and Priorities Research and Development to Improve HHS Data Collection Systems Web Panels and Web Surveys
HHS Implementation Guidance on Data Collection Standards for Race, Ethnicity, Sex, Primary Language, and Disability Status
This policy guidance provides information on the final set of data standards for race, ethnicity, sex, primary language, and disability status as required by Section 4302 of the Affordable Care Act. Supporting guidance on implementation of the standards is provided for inclusion on all population health surveys, to the extent practicable, conducted or sponsored by HHS
Policy Research for Front of Package Nutrition Labeling: Developing and Testing a Summary System Algorithm
Prepared for Kathleen Koehler Department of Health and Human Services Office of Assistant Secretary for Planning and Evaluation Office of Science and Data Policy 200 Independence Avenue SW Washington, DC 20201 Prepared by
An Assessment of the State of the Art for Measuring Burden of Illness
Prepared for: Ansalan Stewart U.S. Department of Health and Human Services Prepared by: Amanda A. Honeycutt, Thomas Hoerger, Alex Hardee, Linda Brown, and Kevin Smith RTI International RTI Project Number: 0212050.005.001 Background
Environmental Scan
Policy Research for Front of Package Nutrition Labeling: Environmental Scan and Literature Review
Policy Research for Front of Package Nutrition Labeling: Environmental Scan and Literature Review Final Report February 2011 Contract No. HHSP23320095651WC
Expanding the Use of Generic Drugs
Dramatic growth in the use of generic drugs has generated substantial savings for American consumers. To examine how the Department of Health and Human Services (HHS) can encourage the use of generic drugs, the Assistant Secretary for Planning and Evaluation (ASPE) examined barriers to, and opportunities for, expanding the use of generic drugs.